Which of the following is most effectively treated with ECT?

Papers of special note have been highlighted as:

▪ of interest

1. Leiknes KA, Jarosh-von Schweder L, Hoie B. Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behav. 2012;2(3):283–344. [PMC free article] [PubMed] [Google Scholar]

2. Hermann RC, Dorwart RA, Hoover CW, Brody J. Variation in ECT use in the United States. Am.. J. Psychiatry. 1995;152(6):869–875. [PubMed] [Google Scholar]

3. Rosenbach ML, Hermann RC, Dorwart RA. Use of electroconvulsive therapy in the Medicare population between 1987 and 1992. Psychiatr. Serv. 1997;48(12):1537–1542. [PubMed] [Google Scholar]

4. Weiner RD, Prudic J. Electroconvulsive therapy in the United States: how often is it used? Biol. Psychiatry. 2013;73(2):105–106. [PubMed] [Google Scholar]. ▪ Regardless of utilization rate, it is clear that electroconvulsive therapy (ECT) remains the most effective and rapidly active treatment modality for use in the management of certain mental disorders, most notably major depression. It is particularly impressive that this advantage of ECT has remained in spite of an ever-increasing array of psychopharmacologic and psychotherapeutic alternatives.

5. Thompson JW, Weiner RD, Myers CP. Use of ECT in the United States in 1975, 1980, and 1986. Am. J. Psychiatry. 1994;151(11):1657–1661. [PubMed] [Google Scholar]

6. Roose SP, Sackeim HA, Krishnan KR, et al. Old-Old Depression Study Group. Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am. J. Psychiatry. 2004;161(11):2050–2059. [PubMed] [Google Scholar]

7. Schatzberg AF, Kraemer HC. Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression. Biol. Psychiatry. 2000;47(8):736–744. [PubMed] [Google Scholar]

8. Roose SP, Sackeim HA. Clinical trials in late-life depression: revisited. Am. J. Geriatr. Psychiatry. 2002;10(5):503–505. [PubMed] [Google Scholar]

9. Roose SP, Schatzberg AF. The efficacy of antidepressants in the treatment of late-life depression. J. Clin. Psychopharmacol. 2005;25(4) Suppl. 1:S1–S7. [PubMed] [Google Scholar]

10. Sneed JR, Culang-Reinlieb ME, Brickman AM, et al. MRI signal hyperintensities and failure to remit following antidepressant treatment. J. Affect. Disord. 2011;135(1–3):315–320. [PubMed] [Google Scholar]

11. Alexopoulos GS, Murphy CF, Gunning-Dixon FM, et al. Microstructural white matter abnormalities and remission of geriatric depression. Am. J. Psychiatry. 2008;165(2):238–244. [PubMed] [Google Scholar]

12. Navarro V, Gastó C, Lomeña F, et al. Prognostic value of frontal functional neuroimaging in late-onset severe major depression. Br. J. Psychiatry. 2004;184:306–311. [PubMed] [Google Scholar]

13. Taylor WD, Steffens DC, MacFall JR, et al. White matter hyperintensity progression and late-life depression outcomes. Arch. Gen. Psychiatry. 2003;60(11):1090–1096. [PubMed] [Google Scholar]

14. American Psychiatric Association. Task Force on Electroconvulsive Therapy. The practice of ECT: recommendations for treatment, training and privileging. Convuls. Ther. 1990;6(2):85–120. [PubMed] [Google Scholar]

15. Benbow SM. The role of electroconvulsive therapy in the treatment of depressive illness in old age. Br. J. Psychiatry. 1989;155:147–152. [PubMed] [Google Scholar]

16. Tew JD, Jr, Mulsant BH, Haskett RF, et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am. J. Psychiatry. 1999;156(12):1865–1870. [PubMed] [Google Scholar]. ▪ Despite a higher level of physical illness and cognitive impairment, even the oldest patients with severe major depression tolerate ECT in a manner similar to that of younger patients, and demonstrate a similar or better acute response.

17. Endler NS. The origins of electroconvulsive therapy (ECT) Convuls. Ther. 1988;4(1):5–23. [PubMed] [Google Scholar]

18. Slater ET. Evaluation of electric convulsion therapy as compared with conservative methods of treatment in depressive states. J. Ment. Sci. 1951;97(408):567–569. [PubMed] [Google Scholar]

19. Karagulla S. Evaluation of electric convulsion therapy as compared with conservative methods of treatment in depressive states. J. Ment. Sci. 1950;96(405):1060–1091. [PubMed] [Google Scholar]

20. Consensus conference. Electroconvulsive therapy. JAMA. 1985;254(15):2103–2108. [PubMed] [Google Scholar]

21. Avery D, Winokur G. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch. Gen. Psychiatry. 1976;33(9):1029–1037. [PubMed] [Google Scholar]

22. Kral VA. Somatic therapies in older depressed patients. J. Gerontol. 1976;31(3):311–313. [PubMed] [Google Scholar]

23. Winslade WJ, Liston EH, Ross JW, Weber KD. Medical, judicial, statutory regulation of ECT in the United States. Am. J. Psychiatry. 1984;141(11):1349–1355. [PubMed] [Google Scholar]

24. APA Task Force report calls ECT a valuable treatment for some affective disorders. Hosp. Community Psychiatry. 1979;30(2):144–147. [PubMed] [Google Scholar]

25. Runck B. NIMH report. Consensus panel backs cautious use of ECT for severe disorders. Hosp. Community Psychiatry. 1985;36(9):943–946. [PubMed] [Google Scholar]

26. Fink M. The practice of ECT: recommendations for treatment, training, and privileging – background. Convuls. Ther. 1990;6(2):82–84. [PubMed] [Google Scholar]

27. Janicak PG, Davis JM, Gibbons RD, Ericksen S, Chang S, Gallagher P. Efficacy of ECT: a meta-analysis. Am. J. Psychiatry. 1985;142(3):297–302. [PubMed] [Google Scholar]

28. Folkerts HW, Michael N, Tölle R, Schonauer K, Mücke S, Schulze-Mönking H. Electroconvulsive therapy vs. paroxetine in treatment-resistant depression – a randomized study. Acta Psychiatr. Scand. 1997;96(5):334–342. [PubMed] [Google Scholar]

29. Gangadhar BN, Kapur RL, Kalyanasundaram S. Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double blind study. Br. J. Psychiatry. 1982;141:367–371. [PubMed] [Google Scholar]

30. Small JG, Klapper MH, Kellams JJ, et al. Electroconvulsive treatment compared with lithium in the management of manic states. Arch. Gen. Psychiatry. 1988;45(8):727–732. [PubMed] [Google Scholar]

31. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am. J. Psychiatry. 1994;151(2):169–176. [PubMed] [Google Scholar]

32. Aziz R, Lorberg B, Tampi RR. Treatments for late-life bipolar disorder. Am. J. Geriatr. Pharmacother. 2006;4(4):347–364. [PubMed] [Google Scholar]

33. Fink M, Sackeim HA. Convulsive therapy in schizophrenia? Schizophr. Bull. 1996;22(1):27–39. [PubMed] [Google Scholar]

34. Abraham KR, Kulhara P. The efficacy of electroconvulsive therapy in the treatment of schizophrenia. A comparative study. Br. J. Psychiatry. 1987;151:152–155. [PubMed] [Google Scholar]

35. Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S. Leicester ECT trial: results in schizophrenia. Br. J. Psychiatry. 1985;146:177–183. [PubMed] [Google Scholar]

36. Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst. Rev. 2005;2:CD000076. [PubMed] [Google Scholar]

37. Kupchik M, Spivak B, Mester R, et al. Combined electroconvulsive–clozapine therapy. Clin. Neuropharmacol. 2000;23(1):14–16. [PubMed] [Google Scholar]

38. Goswami U, Kumar U, Singh B. Efficacy of electroconvulsive therapy in treatment resistant schizophreinia : a double-blind study. Indian J. Psychiatry. 2003;45(1):26–29. [PMC free article] [PubMed] [Google Scholar]

39. Deshmukh DK, Sethna KJ, Nagesh RP, Haridas RM, Patankar SV. A comparative study to evaluate the efficacy of spaced v/s daily electroconvulsive therapy in schizophrenia. Indian J. Psychiatry. 1980;22(4):366–367. [PMC free article] [PubMed] [Google Scholar]

40. Janakiramaiah N, Subbakrishan DK. Ect-chlorpromazine combination compared with chlorpromazine only in schizophrenia. Indian J. Psychiatry. 1981;23(3):230–233. [PMC free article] [PubMed] [Google Scholar]

41. Natani GD, Gautam S, Gehlot PS. Comparison of three treatment regimes in schizophrenia. Indian J. Psychiatry. 1983;25(4):306–311. [PMC free article] [PubMed] [Google Scholar]

42. Suzuki K, Awata S, Takano T, Ebina Y, Iwasaki H, Matsuoka H. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia. Psychiatry Clin. Neurosci. 2005;59(4):481–489. [PubMed] [Google Scholar]

43. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch. Gen. Psychiatry. 2000;57(5):425–434. [PubMed] [Google Scholar]. ▪ Right unilateral ECT at high dosage is as effective as a robust form of bilateral ECT, but produces less severe and persistent cognitive effects.

44. McCall WV, Reboussin DM, Weiner RD, Sackeim HA. Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch. Gen. Psychiatry. 2000;57(5):438–444. [PubMed] [Google Scholar]

45. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285(10):1299–1307. [PubMed] [Google Scholar]. ▪ Indicates that without active treatment, virtually all remitted patients relapse within 6 months of stopping ECT. Monotherapy with nortriptyline has limited efficacy. The combination of nortriptyline and lithium is more effective, but the relapse rate is still high, particularly during the first month of continuation therapy.

46. Prudic J, Haskett RF, McCall WV, et al. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J. ECT. 2013;29(1):3–12. [PMC free article] [PubMed] [Google Scholar]. ▪ Starting an antidepressant medication during ECT does not affect relapse. Nortriptyline and venlafaxine were equally effective in prolonging remission, although relapse rates after ECT are substantial despite intensive pharmacology.

47. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. [PMC free article] [PubMed] [Google Scholar]

48. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch. Gen. Psychiatry. 2001;58(8):721–728. [PubMed] [Google Scholar]

49. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur. Heart J. 2006;27(23):2763–2774. [PubMed] [Google Scholar]

50. González HM, Tarraf W, Whitfield KE, Vega WA, et al. The epidemiology of major depression and ethnicity in the United States. J. Psychiatr. Res. 2010;44(15):1043–1051. [PMC free article] [PubMed] [Google Scholar]

51. Diagnosis and treatment of depression in late life. NIH Consensus Development Conference. November 4–6, 1991. NIH Consens. Statement. 1991;9(3):1–27. [PubMed] [Google Scholar]

52. Penninx BW, Geerlings SW, Deeg DJ, van Eijk JT, van Tilburg W, Beekman AT. Minor and major depression and the risk of death in older persons. Arch. Gen. Psychiatry. 1999;56(10):889–895. [PubMed] [Google Scholar]

53. Kay DW, Bergmann K. Physical disability and mental health in old age. A follow-up of a random sample of elderly people seen at home. J. Psychosom. Res. 1966;10(1):3–12. [PubMed] [Google Scholar]

54. Stanley WJ, Fleming H. A clinical comparison of phenelzine and electro-convulsive therapy in the treatment of depressive illness. J. Ment. Sci. 1962;108:708–710. [PubMed] [Google Scholar]

55. McDonald IM, Perkins M, Marjerrison G, Podilsky M. A controlled comparison of amitriptyline and electroconvulsive therapy in the treatment of depression. Am. J. Psychiatry. 1966;122(12):1427–1431. [PubMed] [Google Scholar]

56. Janakiramaiah N, Gangadhar BN, Naga Venkatesha Murthy PJ, Harish MG, Subbakrishna DK, Vedamurthachar A. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramine. J. Affect. Disord. 2000;57(1–3):255–259. [PubMed] [Google Scholar]

57. Husain MM, Rush AJ, Fink M, et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. J. Clin. Psychiatry. 2004;65(4):485–491. [PubMed] [Google Scholar]

58. Rush AJ, Trivedi M, Fava M. Depression, IV: STAR*D treatment trial for depression. Am. J. Psychiatry. 2003;160(2):237. [PubMed] [Google Scholar]

59. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am. J. Psychiatry. 1996;153(8):985–992. [PubMed] [Google Scholar]

60. Khalid N, Atkins M, Tredget J, Giles M, Champney-Smith K, Kirov G. The effectiveness of electroconvulsive therapy in treatment-resistant depression: a naturalistic study. J. ECT. 2008;24(2):141–145. [PubMed] [Google Scholar]

61. Dombrovski AY, Mulsant BH, Haskett RF, Prudic J, Begley AE, Sackeim HA. Predictors of remission after electroconvulsive therapy in unipolar major depression. J. Clin. Psychiatry. 2005;66(8):1043–1049. [PubMed] [Google Scholar]

62. O’Connor MK, Knapp R, Husain M, et al. The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. Am. J. Geriatr. Psychiatry. 2001;9(4):382–390. [PubMed] [Google Scholar]

63. Tomac TA, Rummans TA, Pileggi TS, Li H. Safety and efficacy of electroconvulsive therapy in patients over age 85. Am. J. Geriatr. Psychiatry. 1997;5(2):126–130. [PubMed] [Google Scholar]

64. Williams JH, O’Brien JT, Cullum S. Time course of response to electroconvulsive therapy in elderly depressed subjects. Int. J. Geriatr. Psychiatry. 1997;12(5):563–566. [PubMed] [Google Scholar]

65. Philibert RA, Richards L, Lynch CF, Winokur G. Effect of ECT on mortality and clinical outcome in geriatric unipolar depression. J. Clin. Psychiatry. 1995;56(9):390–394. [PubMed] [Google Scholar]

66. Parker G, Roy K, Hadzi-Pavlovic D, Wilhelm K, Mitchell P. The differential impact of age on the phenomenology of melancholia. Psychol. Med. 2001;31(7):1231–1236. [PubMed] [Google Scholar]

67. Fink M, Rush AJ, Knapp R, et al. Consortium for Research in ECT (CORE) Study Group. DSM melancholic features are unreliable predictors of ECT response: a CORE publication. J. ECT. 2007;23(3):139–146. [PubMed] [Google Scholar]

68. Prudic J, Devanand DP, Sackeim HA, Decina P, Kerr B. Relative response of endogenous and non-endogenous symptoms to electroconvulsive therapy. J. Affect. Disord. 1989;16(1):59–64. [PubMed] [Google Scholar]

69. Cronholm B, Ottosson JO. Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression. The role of the electrical stimulation and of the seizure studied by variation of stimulus intensity and modification by lidocaine of seizure discharge. Convuls. Ther. 1996;12(3):172–194. [PubMed] [Google Scholar]

70. Meyers BS, Kalayam B, Mei-Tal V. Late-onset delusional depression: a distinct clinical entity? J. Clin. Psychiatry. 1984;45(8):347–349. [PubMed] [Google Scholar]

71. Roose SP, Glassman AH, Walsh BT, Woodring S, Vital-Herne J. Depression, delusions, and suicide. Am. J. Psychiatry. 1983;140(9):1159–1162. [PubMed] [Google Scholar]

72. Johnson J, Horwath E, Weissman MM. The validity of major depression with psychotic features based on a community study. Arch. Gen. Psychiatry. 1991;48(12):1075–1081. [PubMed] [Google Scholar]

73. Baldwin RC. Delusional and non-delusional depression in late life. Evidence for distinct subtypes. Br. J. Psychiatry. 1988;152:39–44. [PubMed] [Google Scholar]

74. O’Leary D, Gill D, Gregory S, Shawcross C. Which depressed patients respond to ECT? The Nottingham results. J. Affect. Disord. 1995;33(4):245–250. [PubMed] [Google Scholar]

75. Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J. ECT. 2001;17(4):244–253. [PubMed] [Google Scholar]

76. Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res. 1990;31(3):287–296. [PubMed] [Google Scholar]

77. Klap R, Unroe KT, Unutzer J. Caring for mental illness in the United States: a focus on older adults. Am. J. Geriatr. Psychiatry. 2003;11(5):517–524. [PubMed] [Google Scholar]

78. Koenig HG, Blazer DG. Epidemiology of geriatric affective disorders. Clin. Geriatr. Med. 1992;8(2):235–251. [PubMed] [Google Scholar]

79. Sajatovic M, Blow FC, Ignacio RV, Kales HC. New-onset bipolar disorder in later life. Am. J. Geriatr. Psychiatry. 2005;13(4):282–289. [PubMed] [Google Scholar]

80. Depp CA, Jeste DV. Bipolar disorder in older adults: a critical review. Bipolar Disord. 2004;6(5):343–367. [PubMed] [Google Scholar]

81. D’Souza R, Rajji TK, Mulsant BH, Pollock BG. Use of lithium in the treatment of bipolar disorder in late-life. Curr. Psychiatry Rep. 2011;13(6):488–492. [PubMed] [Google Scholar]

82. Young RC, Gyulai L, Mulsant BH, et al. Pharmacotherapy of bipolar disorder in old age: Review and recommendations. Am. J. Geriatr. Psychiatry. 2004;12(4):342–357. [PubMed] [Google Scholar]

83. Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging. 2000;16(3):165–177. [PubMed] [Google Scholar]

84. Dierckx B, Heijnen WT, van den Broek WW, Birkenhäger TK. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. Bipolar Disord. 2012;14(2):146–150. [PubMed] [Google Scholar]

85. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N. Engl. J. Med. 1993;328(12):839–846. [PubMed] [Google Scholar]

86. Sackeim HA, Ross FR, Hopkins N, Calev L, Devanand DP. Subjective side effects acutely following ECT: associations with treatment modality and clinical response. Convuls. Ther. 1987;3(2):100–110. [PubMed] [Google Scholar]

87. Daly JJ, Prudic J, Devanand DP, et al. ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord. 2001;3(2):95–104. [PubMed] [Google Scholar]

88. Agarkar S, Hurt S, Lisanby S, Young RC. ECT use in unipolar and bipolar depression. J. ECT. 2012;28(3):e39–e40. [PMC free article] [PubMed] [Google Scholar]

89. Sienaert P, Vansteelandt K, Demyttenaere K, Peuskens J. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response. Bipolar Disord. 2009;11(4):418–424. [PubMed] [Google Scholar]

90. Fink M. How does convulsive therapy work? Neuropsychopharmacology. 1990;3(2):73–82. [PubMed] [Google Scholar]

91. Black DW, Winokur G, Nasrallah A. ECT in unipolar and bipolar disorders: a naturalistic evaluation of 460 patients. Convuls. Ther. 1986;2(4):231–237. [PubMed] [Google Scholar]

92. McCabe MS. ECT in the treatment of mania: a controlled study. Am. J. Psychiatry. 1976;133(6):688–691. [PubMed] [Google Scholar]

93. Thomas J, Reddy B. The treatment of mania. A retrospective evaluation of the effects of ECT, chlorpromazine, and lithium. J. Affect. Disord. 1982;4(2):85–92. [PubMed] [Google Scholar]

94. Volpe FM, Tavares A. Manic patients receiving ECT in a Brazilian sample. J. Affect. Disord. 2004;79(1–3):201–208. [PubMed] [Google Scholar]

95. Medda P, Perugi G, Zanello S, Ciuffa M, Cassano GB. Response to ECT in bipolar I, bipolar II and unipolar depression. J. Affect. Disord. 2009;118(1–3):55–59. [PubMed] [Google Scholar]

96. Abrams R, Fink M. The present status of unilateral ECT. Some recommendations. J. Affect. Disord. 1984;7(3–4):245–247. [PubMed] [Google Scholar]

97. Small JG, Small IF, Milstein V, Kellams JJ, Klapper MH. Manic symptoms: an indication for bilateral ECT. Biol. Psychiatry. 1985;20(2):125–134. [PubMed] [Google Scholar]

98. Milstein V, Small JG, Klapper MH, Small IF, Miller MJ, Kellams JJ. Uni-versus bilateral ECT in the treatment of mania. Convuls. Ther. 1987;3(1):1–9. [PubMed] [Google Scholar]

99. Mukherjee S, Sackeim HA, Lee C. Unilateral ECT in the treatment of manic episodes. Convuls. Ther. 1988;4(1):74–80. [PubMed] [Google Scholar]

100. Devanand DP, Polanco P, Cruz R, et al. The efficacy of ECT in mixed affective states. J. ECT. 2000;16(1):32–37. [PubMed] [Google Scholar]

101. Koukopoulos A, Sani G, Koukopoulos AE, et al. Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients. J. Affect. Disord. 2003;73(1–2):75–85. [PubMed] [Google Scholar]

102. Zavorotnyy M, Diemer J, Patzelt J, Behnken A, Zwanzger P. Occurence of ultra-rapid cycling during electroconvulsive therapy in bipolar depression. World J. Biol. Psychiatry. 2009;10(4 Pt 3):987–990. [PubMed] [Google Scholar]

103. Dolenc TJ, Rasmussen KG. The safety of electroconvulsive therapy and lithium in combination: a case series and review of the literature. J. ECT. 2005;21(3):165–170. [PubMed] [Google Scholar]

104. Volpe FM, Tavares AR. Lithium plus ECT for mania in 90 cases: safety issues. J. Neuropsychiatry Clin. Neurosci. 2012;24(4):E33. [PubMed] [Google Scholar]

105. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am. J. Psychiatry. 1994;151(2):169–176. [PubMed] [Google Scholar]

106. Jobe TH, Harrow M. Long-term outcome of patients with schizophrenia: a review. Can. J. Psychiatry. 2005;50(14):892–900. [PubMed] [Google Scholar]

107. Lehnhardt FG, Konkol C, Kuhn J. Use of ECT in drug-refractory schizophrenia – a survey of the current literature. Fortschr. Neurol. Psychiatr. 2012;80(9):501–511. [PubMed] [Google Scholar]

108. Mouchet-Mages S. Electroconvulsive therapy and schizophrenia. Encephale. 2007;33(Pt 3):S415–S418. [PubMed] [Google Scholar]

109. Kales HC, Dequardo JR, Tandon R. Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1999;23(3):547–556. [PubMed] [Google Scholar]

110. Gazdag G, Kocsis-Ficzere N, Tolna J. The augmentation of clozapine treatment with electroconvulsive therapy. Ideggyogy. Sz. 2006;59(7–8):261–267. [PubMed] [Google Scholar]

111. Kho KH, Blansjaar BA, de Vries S, Babuskova D, Zwinderman AH, Linszen DH. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia – an open label study. Eur. Arch. Psychiatry Clin. Neurosci. 2004;254(6):372–379. [PubMed] [Google Scholar]

112. Philbrick KL, Rummans TA. Malignant catatonia. J. Neuropsychiatry Clin. Neurosci. 1994;6(1):1–13. [PubMed] [Google Scholar]

113. Swartz C, Galang RL. Adverse outcome with delay in identification of catatonia in elderly patients. Am. J. Geriatr. Psychiatry. 2001;9(1):78–80. [PubMed] [Google Scholar]

114. Jaimes-Albornoz W, Serra-Mestres J. Catatonia in the emergency department. Emerg. Med. J. 2012;29(11):863–867. [PubMed] [Google Scholar]

115. Valenstein M, Maltbie A, Kaplan P. Catatonia in the emergency department. Ann. Emerg. Med. 1985;14(4):359–361. [PubMed] [Google Scholar]

116. Detweiler MB, Mehra A, Rowell T, Kim KY, Bader G. Delirious mania and malignant catatonia: a report of 3 cases and review. Psychiatr. Q. 2009;80(1):23–40. [PubMed] [Google Scholar]

117. Zervas IM, Theleritis C, Soldatos CR. Using ECT in schizophrenia: a review from a clinical perspective. World J. Biol. Psychiatry. 2012;13(2):96–105. [PubMed] [Google Scholar]

118. Suzuki K, Awata S, Matsuoka H. Short-term effect of ECT in middle-aged and elderly patients with intractable catatonic schizophrenia. J. ECT. 2003;19(2):73–80. [PubMed] [Google Scholar]

119. Suzuki K, Awata S, Takano T, et al. Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone. Psychiatry Clin. Neurosci. 2006;60(4):486–492. [PubMed] [Google Scholar]

120. Starkstein SE, Petracca G, Tesón A, et al. Catatonia in depression: prevalence, clinical correlates, validation of a scale. J. Neurol. Neurosurg. Psychiatry. 1996;60(3):326–332. [PMC free article] [PubMed] [Google Scholar]

121. Swartz CM, Morrow V, Surles L, James JF. Long-term outcome after ECT for catatonic depression. J. ECT. 2001;17(3):180–183. [PubMed] [Google Scholar]

122. Taylor MA, Abrams R. Catatonia. Prevalence and importance in the manic phase of manic-depressive illness. Arch. Gen. Psychiatry. 1977;34(10):1223–1225. [PubMed] [Google Scholar]

123. Fink M. Delirious mania. Bipolar Disord. 1999;1(1):54–60. [PubMed] [Google Scholar]

124. White DA, Robins AH. Catatonia: harbinger of the neuroleptic malignant syndrome. Br. J. Psychiatry. 1991;158:419–421. [PubMed] [Google Scholar]

125. White DA. Catatonia and the neuroleptic malignant syndrome – a single entity? Br. J. Psychiatry. 1992;161:558–560. [PubMed] [Google Scholar]

126. White DA, Robins AH. An analysis of 17 catatonic patients diagnosed with neuroleptic malignant syndrome. CNS Spectr. 2000;5(7):58–65. [PubMed] [Google Scholar]

127. Luchini F, Lattanzi L, Bartolommei N, et al. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports. J. Nerv. Ment. Dis. 2013;201(1):36–42. [PubMed] [Google Scholar]

128. Trollor JN, Sachdev PS. Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust. N. Z. J. Psychiatry. 1999;33(5):650–659. [PubMed] [Google Scholar]

129. Luchini F, Lattanzi L, Bartolommei N, et al. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports. Riv. Psichiatr. 2012;47(2):178–185. [PubMed] [Google Scholar]

130. Casamassima F, Lattanzi L, Perlis RH, et al. Neuroleptic malignant syndrome: further lessons from a case report. Psychosomatics. 2010;51(4):349–354. [PubMed] [Google Scholar]

131. Askenazy F, Dor E, Benoit M, et al. Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up. Encephale. 2010;36(1):46–53. [PubMed] [Google Scholar]

132. Berardi D, Amore M, Keck PE, Jr, Troia M, Dell’Atti M. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case–control study. Biol. Psychiatry. 1998;44(8):748–754. [PubMed] [Google Scholar]

133. Cottencin O, Warembourg F, de Chouly de Lenclave MB, et al. Catatonia and consultation-liaison psychiatry study of 12 cases. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2007;31(6):1170–1176. [PubMed] [Google Scholar]

134. Aloysi AS, Popeo DM, Kellner CH. Cases of catatonia on an academic electroconvulsive therapy service: lessons to learn. J. ECT. 2011;27(3):259–261. [PubMed] [Google Scholar]

135. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr. Scand. 1996;93(2):137–143. [PubMed] [Google Scholar]

136. Morena G, Sunderland B, Billig N. Midazolam and the treatment of catatonia in major depression in an older adult. Psychosomatics. 1994;35(4):392–395. [PubMed] [Google Scholar]

137. Carpenter SS, Hatchett AD, Fuller MA. Catatonic schizophrenia and the use of memantine. Ann. Pharmacother. 2006;40(2):344–346. [PubMed] [Google Scholar]

138. Obregon DF, Velasco RM, Wuerz TP, Catalano MC, Catalano G, Kahn D. Memantine and catatonia: a case report and literature review. J. Psychiatr. Pract. 2011;17(4):292–299. [PubMed] [Google Scholar]

139. McDaniel WW, Spiegel DR, Sahota AK. Topiramate effect in catatonia: a case series. J. Neuropsychiatry Clin. Neurosci. 2006;18(2):234–238. [PubMed] [Google Scholar]

140. Hervey WM, Stewart JT, Catalano G. Treatment of catatonia with amantadine. Clin. Neuropharmacol. 2012;35(2):86–87. [PubMed] [Google Scholar]

141. Raveendranathan D, Narayanaswamy JC, Reddi SV. Response rate of catatonia to electroconvulsive therapy and its clinical correlates. Eur. Arch. Psychiatry Clin. Neurosci. 2012;262(5):425–430. [PubMed] [Google Scholar]

142. Koek RJ, Mervis JR. Treatment-refractory catatonia, ECT, and parenteral lorazepam. Am. J. Psychiatry. 1999;156(1):160–161. author reply 161. [PubMed] [Google Scholar]

143. Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson’s disease: drug-induced psychiatric states. Adv. Neurol. 1995;65:115–138. [PubMed] [Google Scholar]

144. Holcomb HH, Sternberg DE, Heninger GR. Effects of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems. Biol. Psychiatry. 1983;18(8):865–873. [PubMed] [Google Scholar]

145. Avorn J, Bohn RL, Mogun H, et al. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case–control study. Am. J. Med. 1995;99(1):48–54. [PubMed] [Google Scholar]

146. Thanvi B, Treadwell S. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad. Med. J. 2009;85(1004):322–326. [PubMed] [Google Scholar]

147. Kalish SC, Bohn RL, Mogun H, Glynn RJ, Gurwitz JH, Avorn J. Antipsychotic prescribing patterns and the treatment of extrapyramidal symptoms in older people. J. Am. Geriatr. Soc. 1995;43(9):967–973. [PubMed] [Google Scholar]

148. Baez MA, Avery J. Improvement in drug-induced parkinsonism with electroconvulsive therapy. Am. J. Geriatr. Pharmacother. 2011;9(3):190–193. [PubMed] [Google Scholar]

149. Sadananda SK, Holla B, Viswanath B, et al. Effectiveness of electroconvulsive therapy for drug-induced parkinsonism in the elderly. J. ECT. 2013;29(1):e6–e7. [PubMed] [Google Scholar]

150. Hermesh H, Aizenberg D, Friedberg G, Lapidot M, Munitz H. Electroconvulsive therapy for persistent neuroleptic-induced akathisia and parkinsonism: a case report. Biol. Psychiatry. 1992;31(4):407–411. [PubMed] [Google Scholar]

151. Hanin B, Lerner Y, Srour N. An unusual effect of ECT on drug-induced parkinsonism and tardive dystonia. Convuls. Ther. 1995;11(4):271–274. [PubMed] [Google Scholar]

152. Andersen K, Balldin J, Gottfries CG, et al. A double-blind evaluation of electroconvulsive therapy in Parkinson’s disease with ‘on-off ’ phenomena. Acta Neurol. Scand. 1987;76(3):191–199. [PubMed] [Google Scholar]

153. Balldin J, Granérus AK, Lindstedt G, Modigh K, Wålinder J. Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy. Psychopharmacol. (Berl.) 1982;76(4):371–376. [PubMed] [Google Scholar]

154. Levy LA, Savit JM, Hodes M. Parkinsonism: improvement by electroconvulsive therapy. Arch. Phys. Med. Rehabil. 1983;64(9):432–433. [PubMed] [Google Scholar]

155. Bui E, Delrieu J, Wagner T, et al. Iodine-123 fluoropropyl-carbomethoxy-3-beta-(4-iodophenyltropane) single-photon emission computed tomography findings before and after electroconvulsive therapy in major depressive disorder with parkinsonism. J. ECT. 2011;27(4):331–333. [PubMed] [Google Scholar]

156. Pintor LP, Valldeoriola F, Fernández-Egea E, et al. Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to l-dopa: a pilot study. J. ECT. 2012;28(2):87–91. [PubMed] [Google Scholar]

157. Fall PA, Granerus AK. Maintenance ECT in Parkinson’s disease. J. Neural Transm. 1999;106(7–8):737–741. [PubMed] [Google Scholar]

158. Nymeyer L, Grossberg GT. Delirium in a 75-year-old woman receiving ECT and levodopa. Convuls. Ther. 1997;13(2):114–116. [PubMed] [Google Scholar]

159. Zupancic M, Mahajan A, Handa K. Dementia with lewy bodies: diagnosis and management for primary care providers. Prim. Care Companion CNS Disord. 2011;13(5) pii:PCC.11r01190. [PMC free article] [PubMed] [Google Scholar]

160. Fratiglioni L, Launer LJ, Andersen K, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of populationbased cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11) Suppl. 5:S10–S15. [PubMed] [Google Scholar]

161. Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer’s disease. Am. J. Psychiatry. 1989;146(5):577–587. [PubMed] [Google Scholar]

162. Bassiony MM, Steinberg MS, Warren A, Rosenblatt A, Baker AS, Lyketsos CG. Delusions and hallucinations in Alzheimer’s disease: prevalence and clinical correlates. Int. J. Geriatr. Psychiatry. 2000;15(2):99–107. [PubMed] [Google Scholar]

163. Ropacki SA, Jeste DV. Epidemiology of and risk factors for psychosis of Alzheimer’s disease: a review of 55 studies published from 1990 to 2003. Am. J. Psychiatry. 2005;162(11):2022–2030. [PubMed] [Google Scholar]

164. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer’s disease. III: disorders of mood. Br. J. Psychiatry. 1990;157:81–86. 92–94. [PubMed] [Google Scholar]

165. Alexopoulos GS, Abrams RC. Depression in Alzheimer’s disease. Psychiatr. Clin. North. Am. 1991;14(2):327–340. [PubMed] [Google Scholar]

166. Lyketsos CG, Steele C, Baker L, et al. Major and minor depression in Alzheimer’s disease: prevalence and impact. J. Neuropsychiatry Clin. Neurosci. 1997;9(4):556–561. [PubMed] [Google Scholar]

167. Olfson M, Marcus S, Sackeim HA, Thompson J, Pincus HA. Use of ECT for the inpatient treatment of recurrent major depression. Am. J. Psychiatry. 1998;155(1):22–29. [PubMed] [Google Scholar]

168. Price TR, McAllister TW. Safety and efficacy of ECT in depressed patients with dementia: a review of clinical experience. Convuls. Ther. 1989;5(1):61–74. [PubMed] [Google Scholar]

169. Hausner L, Damian M, Sartorius A, Frölich L. Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia. J. Clin. Psychiatry. 2011;72(1):91–97. [PubMed] [Google Scholar]

170. Oudman E. Is electroconvulsive therapy (ECT) effective and safe for treatment of depression in dementia? A short review. J. ECT. 2012;28(1):34–38. [PubMed] [Google Scholar]

171. Cohen-Mansfield J. Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated. J. Am. Geriatr. Soc. 1986;34(10):722–727. [PubMed] [Google Scholar]

172. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J. Am. Geriatr. Soc. 1990;38(5):553–563. [PubMed] [Google Scholar]

173. Tariot PN. Treatment of agitation in dementia. J. Clin. Psychiatry. 1999;60(Suppl. 8):11–20. [PubMed] [Google Scholar]

174. Deutsch LH, Bylsma FW, Rovner BW, Steele C, Folstein MF. Psychosis and physical aggression in probable Alzheimer’s disease. Am. J. Psychiatry. 1991;148(9):1159–1163. [PubMed] [Google Scholar]

175. Deutsch LH, Bylsma FW, Rovner BW, Steele C, Folstein MF. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N. Engl. J. Med. 2006;355(15):1525–1538. [PubMed] [Google Scholar]

176. Grant JE, Mohan SN. Treatment of agitation and aggression in four demented patients using ECT. J. ECT. 2001;17(3):205–209. [PubMed] [Google Scholar]

177. Ujkaj M, Davidoff DA, Seiner SJ, Ellison JM, Harper DG, Forester BP. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia. Am. J. Geriatr. Psychiatry. 2012;20(1):61–72. [PubMed] [Google Scholar]

178. Miller ME, Siris SG, Gabriel AN. Treatment delays in the course of electroconvulsive therapy. Hosp. Community Psychiatry. 1986;37(8):825–827. [PubMed] [Google Scholar]

179. Linden T, Blomstrand C, Skoog I. Depressive disorders after 20 months in elderly stroke patients: a case–control study. Stroke. 2007;38(6):1860–1863. [PubMed] [Google Scholar]

180. Ghoge H, Sharma S, Sonawalla S, Parikh R. Cerebrovascular diseases and depression. Curr. Psychiatry Rep. 2003;5(3):231–238. [PubMed] [Google Scholar]

181. Carota A, Bogousslavsky J. Mood disorders after stroke. Front. Neurol. Neurosci. 2012;30:70–74. [PubMed] [Google Scholar]

182. Hackett ML, Yang M, Anderson CS, Horrocks JA, House A. Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst. Rev. 2010;2:CD003690. [PubMed] [Google Scholar]

183. Currier MB, Murray GB, Welch CC. Electroconvulsive therapy for post-stroke depressed geriatric patients. J. Neuropsychiatry Clin. Neurosci. 1992;4(2):140–144. [PubMed] [Google Scholar]

184. Prudic J, Peyser S, Sackeim HA. Subjective memory complaints: a review of patient self-assessment of memory after electroconvulsive therapy. J. ECT. 2000;16(2):121–132. [PubMed] [Google Scholar]

185. Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA. Effectiveness of electroconvulsive therapy in community settings. Biol. Psychiatry. 2004;55(3):301–312. [PubMed] [Google Scholar]

186. Berman RM, Prudic J, Brakemeier EL, Olfson M, Sackeim HA. Subjective evaluation of the therapeutic and cognitive effects of electroconvulsive therapy. Brain Stimul. 2008;1(1):16–26. [PubMed] [Google Scholar]

187. Coffey CE, Weiner RD. American Psychiatric Association. The Practice of Electroconvulsive Therapy Recommendations for Treatment, Training, and Privileging. 2nd Edition. Washington, DC: American Psychiatric Association; 2001. p. 355. [Google Scholar]

188. Sackeim HA, Prudic J, Nobler MS, et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul. 2008;1(2):71–83. [PMC free article] [PubMed] [Google Scholar]. ▪ The use of an ultrabrief stimulus markedly reduces adverse cognitive effects, and when coupled with markedly suprathreshold right unilateral ECT, also preserves efficacy.

189. Loo C, Sheehan P, Pigot M, Lyndon W. A report on mood and cognitive outcomes with right unilateral ultrabrief pulsewidth (0.3 ms) ECT and retrospective comparison with standard pulsewidth right unilateral ECT. J. Affect. Disord. 2007;103(1–3):277–281. [PubMed] [Google Scholar]

190. Peterchev AV, Rosa MA, Deng ZD, Prudic J, Lisanby SH. Electroconvulsive therapy stimulus parameters: rethinking dosage. J. ECT. 2010;26(3):159–174. [PMC free article] [PubMed] [Google Scholar]

191. Loo CK, Katalinic N, Martin D, Schweitzer I. A review of ultrabrief pulse width electroconvulsive therapy. Ther. Adv. Chronic Dis. 2012;3(2):69–85. [PMC free article] [PubMed] [Google Scholar]

192. Dunne RA, McLoughlin DM. Systematic review and meta-analysis of bifrontal electroconvulsive therapy versus bilateral and unilateral electroconvulsive therapy in depression. World J. Biol. Psychiatry. 2012;13(4):248–258. [PubMed] [Google Scholar]

193. Coffey CE, Lucke J, Weiner RD, Krystal AD, Aque M. Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT. Biol. Psychiatry. 1995;37(11):777–788. [PubMed] [Google Scholar]

194. McCall WV, Weiner RD, Carroll BJ, et al. Serum prolactin, electrode placement, and the convulsive threshold during ECT. Convuls. Ther. 1996;12(2):81–85. [PubMed] [Google Scholar]

195. Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr. Clin. North. Am. 1991;14(4):803–843. [PubMed] [Google Scholar]

196. Coffey CE, Weiner RD. ECT instrumentation. Biol. Psychiatry. 1988;24(3):361–363. [PubMed] [Google Scholar]

197. Cronholm B, Ottosson JO. Ultrabrief stimulus technique in electroconvulsive therapy. II. Comparative studies of therapeutic effects and memory disturbances in treatment of endogenous depression with the elther es electroshock apparatus and siemens konvulsator III. J. Nerv. Ment. Dis. 1963;137:268–276. [PubMed] [Google Scholar]

198. Sobin C, Sackeim HA, Prudic J, Devanand DP, Moody BJ, McElhiney MC. Predictors of retrograde amnesia following ECT. Am. J. Psychiatry. 1995;152(7):995–1001. [PubMed] [Google Scholar]

199. Reid WH, Keller S, Leatherman M, Mason M. ECT in Texas: 19 months of mandatory reporting. J. Clin. Psychiatry. 1998;59(1):8–13. [PubMed] [Google Scholar]

200. Watts BV, Groft A, Bagian JP, Mills PD. An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system. J. ECT. 2011;27(2):105–108. [PubMed] [Google Scholar]

201. Nuttall GA, Bowersox MR, Douglass SB, et al. Morbidity and mortality in the use of electroconvulsive therapy. J. ECT. 2004;20(4):237–241. [PubMed] [Google Scholar]

202. Rasmussen KG, Jarvis MR, Zorumski CF, et al. Low-dose atropine in electroconvulsive therapy. J. ECT. 1999;15(3):213–221. [PubMed] [Google Scholar]

203. Prudic J, Sackeim HA, Decina P, et al. Acute effects of ECT on cardiovascular functioning: relations to patient and treatment variables. Acta Psychiatr. Scand. 1987;75(4):344–351. [PubMed] [Google Scholar]

204. Swartz CM, Saheba NC. Comparison of atropine with glycopyrrolate for use in ECT. Convuls. Ther. 1989;5(1):56–60. [PubMed] [Google Scholar]

205. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA. 2005;294(4):466–472. [PubMed] [Google Scholar]

206. Webb MC, Coffey CE, Saunders WR, Cress MM, Weiner RD, Sibert TR. Cardiovascular response to unilateral electroconvulsive therapy. Biol. Psychiatry. 1990;28(9):758–766. [PubMed] [Google Scholar]

207. Tess AV, Smetana GW. Medical evaluation of patients undergoing electroconvulsive therapy. N. Engl. J. Med. 2009;360(14):1437–1444. [PubMed] [Google Scholar]

208. Shrestha S, Shrestha BR, Thapa C, Pradhan SN, Thapa R, Adhikari S. Comparative study of esmolol and labetalol to attenuate haemodynamic responses after electroconvulsive therapy. Kathmandu Univ. Med. J. (KUMJ) 2007;5(3):318–323. [PubMed] [Google Scholar]

209. van den Broek WW, Leentjens AF, Mulder PG, Kusuma A, Bruijn JA. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study. Br. J. Anaesth. 1999;83(2):271–274. [PubMed] [Google Scholar]

210. Albin SM, Stevens SR, Rasmussen KG. Blood pressure before and after electroconvulsive therapy in hypertensive and nonhypertensive patients. J. ECT. 2007;23(1):9–10. [PubMed] [Google Scholar]

211. Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA. Cardiovascular complications of ECT in depressed patients with cardiac disease. Am. J. Psychiatry. 1993;150(6):904–909. [PubMed] [Google Scholar]

212. Stern L, Hirschmann S, Grunhaus L. ECT in patients with major depressive disorder and low cardiac output. Convuls. Ther. 1997;13(2):68–73. [PubMed] [Google Scholar]

213. Rivera FA, Lapid MI, Sampson S, Mueller PS. Safety of electroconvulsive therapy in patients with a history of heart failure and decreased left ventricular systolic heart function. J. ECT. 2011;27(3):207–213. [PubMed] [Google Scholar]

214. Devanand DP, Malitz S, Sackeim HA. ECT in a patient with aortic aneurysm. J. Clin. Psychiatry. 1990;51(6):255–256. [PubMed] [Google Scholar]

215. Mueller PS, Barnes RD, Varghese R, Nishimura RA, Rasmussen KG. The safety of electroconvulsive therapy in patients with severe aortic stenosis. Mayo Clin. Proc. 2007;82(11):1360–1363. [PubMed] [Google Scholar]

216. Mueller PS, Albin SM, Barnes RD, Rasmussen KG., Jr Safety of electroconvulsive therapy in patients with unrepaired abdominal aortic aneurysm: report of 8 patients. J. ECT. 2009;25(3):165–169. [PubMed] [Google Scholar]

217. Serby MJ, Lantz M, Chabus BI, Bernay LJ. Takotsubo cardiomyopathy and electroconvulsive treatments: a case study and review. Int. J. Psychiatry Med. 2010;40(1):93–96. [PubMed] [Google Scholar]

218. Celano CM, Torri A, Seiner S. Takotsubo cardiomyopathy after electroconvulsive therapy: a case report and review. J. ECT. 2011;27(3):221–223. [PubMed] [Google Scholar]

219. Satterthwaite TD, Cristancho MA, Alici Y, Weiss D, O’Reardon JP. Electroconvulsive therapy in a 72-year-old woman with a history of Takotsubo cardiomyopathy: a case report and review of the literature. Brain Stimul. 2009;2(4):238–240. [PubMed] [Google Scholar]

220. Kent LK, Weston CA, Heyer EJ, Sherman W, Prudic J. Successful retrial of ECT two months after ECT-induced takotsubo cardiomyopathy. Am. J. Psychiatry. 2009;166(8):857–862. [PubMed] [Google Scholar]

221. Beach SR, Wichman CL, Canterbury RJ. Takotsubo cardiomyopathy following electroconvulsive therapy. J. Cardiovasc. Med. (Hagerstown) 2009;10(4):333–335. [PubMed] [Google Scholar]

222. O’Reardon JP, Lott JP, Akhtar UW, Cristancho P, Weiss D, Jones N. Acute coronary syndrome (Takotsubo cardiomyopathy) following electroconvulsive therapy in the absence of significant coronary artery disease: case report and review of the literature. J. ECT. 2008;24(4):277–280. [PubMed] [Google Scholar]

223. Devanand DP, Decina P, Sackeim HA, Prudic J. Status epilepticus following ECT in a patient receiving theophylline. J. Clin. Psychopharmacol. 1988;8(2):153. [PubMed] [Google Scholar]

224. Williams J, Rosenquist P, Arias L, McCall WV. Pseudocholinesterase deficiency and electroconvulsive therapy. J. ECT. 2007;23(3):198–200. [PubMed] [Google Scholar]

225. Mueller PS, Schak KM, Barnes RD, Rasmussen KG. Safety of electroconvulsive therapy in patients with asthma. Neth. J. Med. 2006;64(11):417–421. [PubMed] [Google Scholar]

226. Figiel GS, Jarvis MR. Electroconvulsive therapy in a depressed patient receiving bupropion. J. Clin. Psychopharmacol. 1990;10:376. [PubMed] [Google Scholar]

227. Sadananda SK, Narayanaswamy JC, Srinivasaraju R, Math SB. Delirium during the course of electroconvulsive therapy in a patient on lithium carbonate treatment. Gen. Hosp. Psychiatry. 2013;35(6):678, e1–e2. [PubMed] [Google Scholar]

228. Rudorfer MV, Manji HK, Potter WZ. ECT and delirium in Parkinson’s disease. Am. J. Psychiatry. 1992;149(12):1758–1759. author reply 1759–1760. [PubMed] [Google Scholar]

229. Kikuchi A, Yasui-Furukori N, Fujii A, Katagai H, Kaneko S. Identification of predictors of post-ictal delirium after electroconvulsive therapy. Psychiatry Clin. Neurosci. 2009;63(2):180–185. [PubMed] [Google Scholar]

230. Figiel GS, Hassen MA, Zorumski C, et al. ECT-induced delirium in depressed patients with Parkinson’s disease. J. Neuropsychiatry Clin. Neurosci. 1991;3(4):405–411. [PubMed] [Google Scholar]

231. Rao V, Lyketsos CG. The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int. J. Geriatr. Psychiatry. 2000;15(8):729–735. [PubMed] [Google Scholar]

232. Kelly KG, Zisselman M. Update on electroconvulsive therapy (ECT) in older adults. J. Am. Geriatr. Soc. 2000;48(5):560–566. [PubMed] [Google Scholar]

233. Figiel GS, Coffey CE, Djang WT, Hoffman G, Jr, Doraiswamy PM. Brain magnetic resonance imaging findings in ECT-induced delirium. J. Neuropsychiatry Clin. Neurosci. 1990;2(1):53–58. [PubMed] [Google Scholar]

234. Figiel GS, Krishnan KR, Doraiswamy PM. Subcortical structural changes in ECT-induced delirium. J. Geriatr. Psychiatry Neurol. 1990;3(3):172–176. [PubMed] [Google Scholar]

235. Martin M, Figiel G, Mattingly G, Zorumski CF, Jarvis MR. ECT-induced interictal delirium in patients with a history of a CVA. J. Geriatr. Psychiatry Neurol. 1992;5(3):149–155. [PubMed] [Google Scholar]

236. Logan CJ, Stewart JT. Treatment of post-electroconvulsive therapy delirium and agitation with donepezil. J. ECT. 2007;23(1):28–29. [PubMed] [Google Scholar]

237. Swartz CM. Electroconvulsive therapy emergence agitation and succinylcholine dose. J. Nerv. Ment. Dis. 1990;178(7):455–457. [PubMed] [Google Scholar]

238. Andersen KL, Videbech P. Treatment of postictal (emergence) delirium after electroconvulsive therapy. Ugeskr. Laeger. 2005;167(35):3313–3314. [PubMed] [Google Scholar]

239. Fraser LM, O’Carroll RE, Ebmeier KP. The effect of electroconvulsive therapy on autobiographical memory: a systematic review. J. ECT. 2008;24(1):10–17. [PubMed] [Google Scholar]

240. Devanand DP, Verma AK, Tirumalasetti F, Sackeim HA. Absence of cognitive impairment after more than 100 lifetime ECT treatments. Am. J. Psychiatry. 1991;148(7):929–932. [PubMed] [Google Scholar]. ▪ The results suggest that patients given many ECT treatments over several courses do not manifest measurable cognitive impairment at long-term follow-up.

241. Prudic J, Olfson M, Sackeim HA. Electro-convulsive therapy practices in the community. Psychol. Med. 2001;31(5):929–934. [PubMed] [Google Scholar]

242. Brodaty H, Hickie I, Mason C, Prenter L. A prospective follow-up study of ECT outcome in older depressed patients. J. Affect. Disord. 2000;60(2):101–111. [PubMed] [Google Scholar]

243. Brodaty H, Berle D, Hickie I, Mason C. ‘Side effects’ of ECT are mainly depressive phenomena and are independent of age. J. Affect. Disord. 2001;66(2–3):237–245. [PubMed] [Google Scholar]

244. Devanand DP, Sackeim HA, Prudic J. Electroconvulsive therapy in the treatment-resistant patient. Psychiatr. Clin. North. Am. 1991;14(4):905–923. [PubMed] [Google Scholar]

245. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE) Arch. Gen. Psychiatry. 2006;63(12):1337–1344. [PMC free article] [PubMed] [Google Scholar]

246. O’Connor DW, Gardner B, Presnell I, Singh D, Tsanglis M, White E. The effectiveness of continuation-maintenance ECT in reducing depressed older patients’ hospital re-admissions. J. Affect. Disord. 2010;120(1–3):62–66. [PubMed] [Google Scholar]. ▪ Suggests that continuation-maintenance ECT is effective in carefully selected patients at high risk of relapse.

247. van Schaik AM, Comijs HC, Sonnenberg CM, Beekman AT, Sienaert P, Stek ML. Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: a systematic review. Am. J. Geriatr. Psychiatry. 2012;20(1):5–17. [PubMed] [Google Scholar]. ▪ On the basis of available literature, maintenance-ECT is probably as effective as continuation medication in severely depressed elderly patients after a successful course of ECT and is generally well tolerated.

248. Chanpattana W, Chakrabhand ML, Sackeim HA, et al. Continuation ECT in treatment-resistant schizophrenia: a controlled study. J. ECT. 1999;15(3):178–192. [PubMed] [Google Scholar]

249. Kellner CH. Brain Stimulation in Psychiatry. ECT, DBS, TMS and Other Modalities. Cambridge, UK: Cambridge University Press; 2012. Magnetic seizure therapy (MST) pp. 127–130. [Google Scholar]

250. Rowny SB, Cycowicz YM, McClintock SM, Truesdale MD, Luber B, Lisanby SH. Differential heart rate response to magnetic seizure therapy (MST) relative to electroconvulsive therapy: a nonhuman primate model. Neuroimage. 2009;47(3):1086–1091. [PMC free article] [PubMed] [Google Scholar]

251. Allan CL, Ebmeier KP. The use of ECT and MST in treating depression. Int. Rev. Psychiatry. 2011;23(5):400–412. [PubMed] [Google Scholar]

252. McClintock SM, Tirmizi O, Chansard M, Husain MM. A systematic review of the neurocognitive effects of magnetic seizure therapy. Int. Rev. Psychiatry. 2011;23(5):413–423. [PMC free article] [PubMed] [Google Scholar]

What is ECT most effective in treating?

Which disorder is treated with ECT?

Is ECT the most effective treatment for depression?

What condition has the best response to ECT?